Yunpeng Xie

12PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCardiology (incl. cardiovascular diseases)Respiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
Melatonin Mitigates Doxorubicin-Induced Cardiotoxicity by Targeting the USP18/PKM2 Axis Without Compromising Antitumor Efficacy.

|Sep 24, 2026
Targeted Quantitative Metabolomics and Lipidomics Reveal Dysregulated Metabolic Networks and a Serum Candidate Biomarker for Atrial Fibrillation.

|Mar 06, 2026
BRISC Deficiency Drives Heart Failure by Regulating β-Catenin K63 Ubiquitination.

Lu Liu, Guang-Ming Ren, Chen Chen

|Jun 14, 2025
Biochanin a Alleviated Doxorubicin-Induced Cardiotoxicity but Did not Interfere With the Antitumor Effect of Doxorubicin.

Yijin Yang, Zhenyu Feng, Fengying Zhou

|Apr 05, 2025
GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis.

Han Li, Zhenyu Feng, Benke Li

|Mar 05, 2025
CDC20 protects the heart from doxorubicin-induced cardiotoxicity by modulating CCDC69 degradation.

Zhenyu Feng, Ningning Zhang, Liang Wang

Pageof 2

Frequent Collaborators

3 joint publications

Jiawei Liao

2 joint publications

Jie Bai

2 joint publications

Yunlong Xia

2 joint publications

Yunlong Xia